Headquarters
17624 NW WALTUCK CT., PORTLAND, OR 97229-8527, US
PORTLAND, OR, US
From the company
Gamma Biotherapeutics is a private, clinical-stage biotechnology company discovering and developing therapeutics that help the immune system fight cancer. Its lead program M3T01, a FasL-neutralizing monoclonal antibody, is advancing through a Phase 1 first-in-human clinical trial in patients with advanced solid tumors at Providence Cancer Institute in Portland, Oregon.
17624 NW WALTUCK CT., PORTLAND, OR 97229-8527, US
Quantities, certifications, and timing.